KLOW (BPC-157 + TB500/TB4 + KPV + GHK-Cu)
KLOW is a proprietary blend combining BPC-157 (tissue-healing pentadecapeptide), TB-500/TB4 (actin-regulating wound-repair peptide), KPV (a melanocortin-derived tripeptide with anti-inflammatory properties), and GHK-Cu (a copper tripeptide involved in skin remodeling and angiogenesis). No clinical trials have evaluated the combination as formulated, and efficacy cannot be extrapolated from individual component research. Each component has a distinct pharmacological profile and combining them may introduce unknown interaction effects. The blend is marketed for recovery, gut health, and anti-aging, but none of these endpoints are clinically established for this specific combination.
Evidence last reviewed: 04 Apr 2026
Not a routine supplement — not recommended for self-directed use.
Information here is educational only, not a recommendation to use. See our Safety page.
Verify this peptide on CertiPep
certipep.ch — anonymous purity & characterization service
Evidence is from research or clinical settings — does not imply safety outside supervised contexts.
There are no robust clinical trials evaluating KLOW as a combination. Each component has individual research, but their combined effects remain unclear and untested.
Combination evidenceOther/unclear · Other/unclearVery low
No robust published RCTs were identified for this specific multi-peptide blend as a regimen.